MODULO BIO, INC.
Causal machine learning platform integrating computational modeling with iPSC-based in vitro validation to identify microglial disease networks and therapeutic targets in neurodegenerative diseases
- Sector
- Biotech
- Headquarters
- LOS ALTOS, CA
- Founded
- 2021
- Latest Form D
- $5.8M, Nov 2024
- Total capital
- $12.6M
- Federal grants
- $2.9M
- 2 awards · 2023–2024
- Rank in peer group#18 of 36
- Private capital raised
- $9.8M
- 2 Form D · last Nov 2024
- 23 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 3 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$5.8M
- Federal grantHealth and Human S · Phase II · Implementing a coupled system of integrative ML modeling and data validation for elucidating microglial therapeutic targets in neurodegenerative disease$1.4M
- Federal grantHealth and Human S · Phase II · Implementing a coupled system of integrative ML modeling and data validation for elucidating microglial therapeutic targets in neurodegenerative disease$1.5M
- Private capital raisedForm D · SEC · 1st filing$3.9M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 36 peers
Line = medianBiotech · Platform
- Federal grants#18 · top 50%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alda Leu DennisDirectorNamed in SEC Form D filings
- Alexander Scott PattersonDirectorNamed in SEC Form D filings
- Michael HorowitzExecutive Officer, DirectorNamed in SEC Form D filings
- Nicholas Leu SaccomanoDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 3- PendingTherapeutic Compounds And MethodsUSPTOApplication PCTUS2024032992
- PendingTherapeutic Compounds And MethodsUSPTOApplication 63540141
- PendingTherapeutic Compounds And MethodsUSPTOApplication 63472202
Related companies, and why
- IHP THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- Cytoagents, Inc.Similar federal contract value in Biotech · null in contracts
- Aromyx CorpSimilar federal contract value in Biotech · null in contracts
- KAYOTHERA INCSimilar federal contract value in Biotech · null in contracts
- XTRESSE, LLCSimilar federal contract value in Biotech · null in contracts
- Faeth Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .